Bill Snyder

November 28, 2017

Maquat named to receive Vanderbilt Prize in Biomedical Science

Lynne Maquat, PhD, whose work has significantly advanced the understanding of human gene expression, is the recipient of the 2017 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center (VUMC) announced today.

By Bill Snyder
November 20, 2017

15 faculty members elected as AAAS fellows

Fifteen Vanderbilt faculty members conducting a range of biomedical and clinical research have been elected fellows of the American Association for the Advancement of Science. Six of the 15 have received funding through the university’s Trans-Institutional Programs initiative, which facilitates research and teaching collaborations across disciplines and are a core pillar of the university’s Academic Strategic Plan.

By Bill Snyder
autism concept: puzzle
November 16, 2017

Study may point to new treatment approach for ASD

Using sophisticated genome mining and gene manipulation techniques, researchers at Vanderbilt University Medical Center (VUMC) have solved a mystery that could lead to a new treatment approach for autism spectrum disorder (ASD).

By Bill Snyder
November 16, 2017

NFID honors Edwards’ infectious diseases research

Kathryn Edwards, MD, professor of Pediatrics and the Sarah H. Sell and Cornelius Vanderbilt Professor at Vanderbilt University School of Medicine, is the recipient of the 2018 Maxwell Finland Award for Scientific Achievement from the National Foundation for Infectious Diseases (NFID).

By Bill Snyder
November 16, 2017

Phenotyping center a global resource for investigators

This summer the Vanderbilt Mouse Metabolic Phenotyping Center (MMPC) began its 17th year of continuous operation and federal support with a $5.5 million, five-year renewal grant from the National Institutes of Health (NIH).

By Bill Snyder
November 2, 2017

Sweatt, Tansey discuss influence of epigenetics on research

Basic research underway at Vanderbilt University Medical Center is raising hopes that one day it will be possible to reverse memory loss in people with Alzheimer’s disease and stop a major driver of cancer in its tracks.

By Bill Snyder
October 26, 2017

Vanderbilt leads international effort to develop universal flu vaccine

Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world.
By Bill Snyder
October 19, 2017

VCAR science day shines light on addiction’s power

Fatal drug overdoses in Davidson County more than doubled in the past four years and now exceed the death rates for homicides and motor vehicle accidents, yet few people with addiction can obtain the treatment they need, Nashville Mayor Megan Barry said Tuesday.
By Bill Snyder
October 19, 2017

Forum highlights strong clinical, translational research efforts

Clinical and translational research at Vanderbilt University Medical Center (VUMC) is thriving.
By Bill Snyder
October 19, 2017

Vanderbilt’s Sweatt, Tansey set for next Discovery Lecture

How epigenetic regulation of gene transcription forms new memories and triggers cancerous growth is the subject of the next Vanderbilt Discovery Lecture on Oct. 26.
By Bill Snyder
October 16, 2017

Gender, pain and dementia

Understanding sex differences in pain perception could lead to more targeted and effective pain assessment and management strategies in older adults with Alzheimer’s disease.
By Bill Snyder
October 12, 2017

Award honors Conn’s mental health research contributions

P. Jeffrey Conn, Ph.D., founding director of the Vanderbilt Center for Neuroscience Drug Discovery, has won a 2017 Research & Hope Award from the Pharmaceutical Research and Manufacturers of America (PhRMA) for outstanding research in the area of mental health.
By Bill Snyder